Skip to content
healthcare.dev

KEPIVANCE

NDC 66658-113, palifermin, injection, powder, lyophilized, for solution, from Swedish Orphan Biovitrum AB (publ).

Product NDC
66658-113
Status
Listed
Labeler
Swedish Orphan Biovitrum AB (publ)
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125103
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66658-113 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PALIFERMIN5.16 mg/1.2mL

Pharmacologic classes

Fibroblast Growth Factor 7 [CS]; Increased Epithelial Proliferation [PE]; Mucocutaneous Epithelial Cell Growth Factor [EPC]

Package NDCNDC-11Package
66658-113-03666580113033 VIAL, SINGLE-USE in 1 CARTON (66658-113-03) / 1.2 mL in 1 VIAL, SINGLE-USE (66658-113-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/426f6e64-2c20-4a61-6d65-7320426f6e64
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=66658-113

Use it

Look up 66658-113 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66658-113 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66658-113. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.